EUVIMEDEUVIMED entdecken
Crossref

Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer

Andrea M Tomko, Erin G Whynot, Lauren F O'Leary, Denis J Dupré iD

Canadian Journal of Physiology and Pharmacology · 01.08.2022 · 100 (8) · 806-817

DOI: 10.1139/cjpp-2021-0792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.08.2022. Verfasst von Andrea M Tomko und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 4R2, Canada. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms, Cannabinoids, Cannabis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapeutic resistance can limit breast cancer outcomes; therefore, the exploration of novel therapeutic options is warranted. Isolated compounds found in cannabis have previously been shown to exhibit anti-cancer effects, but little is known about their effects in resistant breast cancer. Our study aimed to evaluate the effects of terpenes found in cannabis in in vitro chemotherapy-resistant model of breast cancer. We aimed to identify whether five terpenes found in cannabis produced anti-cancer effects, and whether their effects were improved upon co-treatment with cannabinoids and flavonoids also found in cannabis. Nerolidol and β-caryophyllene produced the greatest cytotoxic effects, activated the apoptotic cascade, and reduced cellular invasion. Combinations with the flavonoid kaempferol potentiated the cytotoxic effects of ocimene, terpinolene, and β-myrcene. Combinations of nerolidol and Δ9-tetrahydrocannabinol or cannabidiol produced variable responses ranging from antagonism and additivity to synergy, depending on concentrations used. Our results indicate that cannabis terpenes, alone or combined with cannabinoids and flavonoids, produced anti-cancer effects in chemotherapy-resistant breast cancer cell lines. This study is a first step in the identification of compounds that could have therapeutic potential in the treatment of resistant breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsCannabinoidsCannabisCannabinoid Receptor AgonistsFemaleFlavonoidsHumansPaclitaxelTerpenes

Stichwörter der Autor:innen

apoptoseapoptosisbreast cancercancer du seincannabischemotherapeutic resistancerésistance à la chimiothérapiesynergiesynergyterpenesterpènes

Substanzen

Antineoplastic AgentsCannabinoid Receptor AgonistsCannabinoidsFlavonoidsTerpenesPaclitaxel

Autor:innen und Institutionen

  • Department of Pharmacology, Dalhousie University, Halifax, NS, B3H 4R2, Canada.

ORCID-Profile: Denis J Dupré

Zitieren

APA

Tomko, A. M., Whynot, E. G., O'Leary, L. F., & Dupré, D. J. (2022). Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer. Canadian Journal of Physiology and Pharmacology, 100(8), 806-817. https://doi.org/10.1139/cjpp-2021-0792

Vancouver

Tomko AM, Whynot EG, O'Leary LF, Dupré DJ. Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer. Canadian Journal of Physiology and Pharmacology. 2022;100(8):806-817. doi:10.1139/cjpp-2021-0792

BibTeX
@article{Tomko2022,
  author = {Tomko, Andrea M and Whynot, Erin G and O'Leary, Lauren F and Dupré, Denis J},
  title = {Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2022},
  volume = {100},
  number = {8},
  pages = {806--817},
  doi = {10.1139/cjpp-2021-0792}
}
Kostenlos starten →